CMR releases first photographs of Versius

CMR Surgical, the British company developing the next generation surgical robot, today releases first-ever photographs of the much-anticipated system, Versius.

Add This Share Buttons

The images show the revolutionary design of the robot, including one of its highly versatile surgical bio-mimicking arms.

The release of the photographs marks a major milestone for CMR, which aims to make minimal access surgery available to all the estimated six million people a year who could benefit and make it easier for laparoscopic surgeons to learn and perform the technique.

Versius was designed to be lightweight and easy to set up. The robotic arms measure their position and force thousands of times a second, making them safe to be around and easy to manoeuvre even during surgery.

The arms and wristed instruments give maximum flexibility to surgeons during a procedure. This ground-breaking design allows them to work in a way that reduces physical and mental effort for the surgeon whilst giving them the ability to undertake more procedures on patients.

Versius – as its name suggests – has been designed to be inherently versatile, with the capability to operate across all four surgical quadrants, allowing it to be used in gynaecology, urology, upper GI and colorectal surgery.

“We’ve designed Versius with surgeons in mind. By equipping them with a remarkable tool, fit for their demanding job, we can change the way surgery is delivered. Having operated in stealth mode for the past three years, I am delighted to be able to show what our amazing team has managed to develop in such a short period of time.” said Martin Frost, CEO of CMR.

 (Image removed)

 

About CMR Surgical

CMR Surgical is a private, British, company developing the next-generation universal robotic system, Versius®, for minimal access (or “keyhole”) surgery.

The vision behind CMR is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics and addressing the six million people who still undergo open surgery each year.

Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1

CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.

Investors in Cambridge Medical Robotics include ABB Technology Ventures, LGT Global, Cambridge Innovation Capital and Escala Capital.

For further information, please visit: https://cmrsurgical.com/

References

(1) Industry Forecast, Accuray Research

__________________________________________



Read more

Looking for something specific?